Epithelial-mesenchymal transition: Implications in cancer progression and metastasis

Current Pharmaceutical Biotechnology

Volumn 12, Issue 11, 2011, Pages 1881-1890

  Gomes, L R ^a   Terra, L F ^a   Sogayar, M C ^a   Labriola, L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; EMT; Invasion; Metastasis; MMP; NF B; RTKs; TGF

Indexed keywords

ACTIVIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ; MATRIX METALLOPROTEINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SMAD PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL DIVISION; CELL INTERACTION; CELL JUNCTION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLON CANCER; COLORECTAL CANCER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; IMMUNITY; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; METASTASIS; NEUROBLASTOMA; OVARY CANCER; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; REVIEW; SQUAMOUS CELL CARCINOMA; THROMBOCYTE; UTERUS CANCER;

EID: 83455224263     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798377102     Document Type: Review

References (131)

1. Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest., 2009, 119(6), 1420-1428.
2. Thiery, J.P.; Acloque, H.; Huang, R.Y.; Nieto, M.A. Epithelialmesenchymal transitions in development and disease. Cell, 2009, 139(5), 871-890.
3. Acloque, H.; Adams, M.S.; Fishwick, K.; Bronner-Fraser, M.; Nieto, M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest., 2009, 119(6), 1438-1449.
4. Moreno-Bueno, G.; Portillo, F.; Cano, A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene, 2008, 27(55), 6958-6969.
5. Peinado, H.; Portillo, F.; Cano, A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol., 2004, 48(5-6), 365-375.
6. Jeanes, A.; Gottardi, C.J.; Yap, A.S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 2008, 27(55), 6920-6929.
7. Wang, X.; Zheng, M.; Liu, G.; Xia, W.; McKeown-Longo, P.J.; Hung, M.C.; Zhao, J. Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res., 2007, 67(15), 7184-7193.
8. Peinado, H.; Olmeda, D.; Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer, 2007, 7(6), 415-428.
9. Batlle, E.; Sancho, E.; Franci, C.; Dominguez, D.; Monfar, M.; Baulida, J.; Garcia De Herreros, A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2000, 2(2), 84-89.
10. Cano, A.; Perez-Moreno, M.A.; Rodrigo, I.; Locascio, A.; Blanco, M.J.; del Barrio, M.G.; Portillo, F.; Nieto, M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2000, 2(2), 76-83.
11. Bolos, V.; Peinado, H.; Perez-Moreno, M.A.; Fraga, M.F.; Esteller, M.; Cano, A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci., 2003, 116(Pt 3), 499-511.
12. Sobrado, V.R.; Moreno-Bueno, G.; Cubillo, E.; Holt, L.J.; Nieto, M.A.; Portillo, F.; Cano, A. The class I bHLH factors E2-2A and E2-2B regulate EMT. J. Cell Sci., 2009, 122(Pt 7), 1014-1024.
13. Yang, J.; Weinberg, R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 2008, 14(6), 818-829.
14. Yang, J.; Mani, S.A.; Donaher, J.L.; Ramaswamy, S.; Itzykson, R.A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 2004, 117(7), 927-939.
15. Zeisberg, M.; Neilson, E. G. Biomarkers for epithelialmesenchymal transitions. J. Clin. Invest., 2009, 119(6), 1429-1437.
16. Carlson, B.M. Stimulation of regeneration in mammals: pipe dream or realistic goal? Wound Repair Regen, 1998, 6(5), 425-433.
17. Kalluri, R.; Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest., 2003, 112(12), 1776-1784.
18. Iwano, M.; Plieth, D.; Danoff, T.M.; Xue, C.; Okada, H.; Neilson, E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest., 2002, 110(3), 341-350.
19. Kiemer, A.K.; Takeuchi, K.; Quinlan, M.P. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene, 2001, 20(46), 6679-6688.
20. Ahmed, N.; Maines-Bandiera, S.; Quinn, M. A.; Unger, W. G.; Dedhar, S.; Auersperg, N. Molecular pathways regulating EGFinduced epithelio-mesenchymal transition in human ovarian surface epithelium. Am. J. Physiol. Cell Physiol., 2006, 290(6), C1532-1542.
21. Bacac, M.; Stamenkovic, I. Metastatic cancer cell. Annu. Rev. Pathol., 2008, 3, 221-247.
22. Tarin, D.; Thompson, E.W.; Newgreen, D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res., 2005, 65(14), 5996-6000; discussion 6000-5991.
23. Thompson, E.W.; Newgreen, D.F.; Tarin, D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res., 2005, 65(14), 5991-5995; discussion 5995.
24. Barrallo-Gimeno, A.; Nieto, M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development, 2005, 132(14), 3151-3161.
25. Kudo-Saito, C.; Shirako, H.; Takeuchi, T.; Kawakami, Y. Cancer metastasis is accelerated through immunosuppression during Snailinduced EMT of cancer cells. Cancer Cell, 2009, 15(3), 195-206.
26. Kajita, M.; McClinic, K.N.; Wade, P.A. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol. Cell Biol., 2004, 24(17), 7559-7566.
27. Kurrey, N.K.; Jalgaonkar, S.P.; Joglekar, A.V.; Ghanate, A.D.; Chaskar, P.D.; Doiphode, R.Y.; Bapat, S.A. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells, 2009, 27(9), 2059-2068.
28. Vega, S.; Morales, A.V.; Ocana, O.H.; Valdes, F.; Fabregat, I.; Nieto, M.A. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev., 2004, 18(10), 1131-1143.
29. Zohn, I.E.; Li, Y.; Skolnik, E.Y.; Anderson, K.V.; Han, J.; Niswander, L. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell, 2006, 125(5), 957-969.
30. Ansieau, S.; Bastid, J.; Doreau, A.; Morel, A.P.; Bouchet, B.P.; Thomas, C.; Fauvet, F.; Puisieux, I.; Doglioni, C.; Piccinin, S.; Maestro, R.; Voeltzel, T.; Selmi, A.; Valsesia-Wittmann, S.; Caron de Fromentel, C.; Puisieux, A. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 2008, 14(1), 79-89.
31. Puisieux, A.; Valsesia-Wittmann, S.; Ansieau, S. A twist for survival and cancer progression. Br. J. Cancer, 2006, 94(1), 13-17.
32. Cheng, G.Z.; Chan, J.; Wang, Q.; Zhang, W.; Sun, C.D.; Wang, L.H. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res., 2007, 67(5), 1979-1987.
33. Li, Q.Q.; Xu, J.D.; Wang, W.J.; Cao, X.X.; Chen, Q.; Tang, F.; Chen, Z.Q.; Liu, X.P.; Xu, Z.D. Twist1-mediated adriamycininduced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin. Cancer Res., 2009, 15(8), 2657-2665.
34. Liu, Y.; El-Naggar, S.; Darling, D.S.; Higashi, Y.; Dean, D.C. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development, 2008, 135(3), 579-588.
35. Inoue, A.; Seidel, M.G.; Wu, W.; Kamizono, S.; Ferrando, A.A.; Bronson, R.T.; Iwasaki, H.; Akashi, K.; Morimoto, A.; Hitzler, J.K.; Pestina, T.I.; Jackson, C.W.; Tanaka, R.; Chong, M.J.; McKinnon, P.J.; Inukai, T.; Grosveld, G.C.; Look, A.T. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell, 2002, 2(4), 279-288.
36. Wu, W.S.; Heinrichs, S.; Xu, D.; Garrison, S.P.; Zambetti, G.P.; Adams, J.M.; Look, A.T. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell, 2005, 123(4), 641-653.
37. Zilfou, J.T.; Spector, M.S.; Lowe, S.W. Slugging it out: fine tuning the p53-PUMA death connection. Cell, 2005, 123(4), 545-548.
38. Geiger, T.R.; Peeper, D.S. Metastasis mechanisms. Biochim. Biophys. Acta, 2009, 1796(2), 293-308.
39. Medici, D.; Hay, E.D.; Olsen, B.R. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell, 2008, 19(11), 4875-4887.
40. Zavadil, J.; Narasimhan, M.; Blumenberg, M.; Schneider, R.J. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs, 2007, 185(1-3), 157-161.
41. Orlichenko, L.S.; Radisky, D.C. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin. Exp. Metastasis, 2008, 25(6), 593-600.
42. Guarino, M. Epithelial-mesenchymal transition and tumour invasion. Int. J. Biochem. Cell Biol., 2007, 39(12), 2153-2160.
43. Gavert, N.; Ben-Ze'ev, A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med., 2008, 14(5), 199-209.
44. Iwatsuki, M.; Mimori, K.; Yokobori, T.; Ishi, H.; Beppu, T.; Nakamori, S.; Baba, H.; Mori, M. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci., 2010, 101(2), 293-299.
45. Guarino, M.; Rubino, B.; Ballabio, G. The role of epithelialmesenchymal transition in cancer pathology. Pathology, 2007, 39(3), 305-318.
46. Stallings-Mann, M.; Radisky, D. Matrix metalloproteinase-induced malignancy in mammary epithelial cells. Cells Tissues Organs, 2007, 185(1-3), 104-110.
47. Nelson, C.M.; Khauv, D.; Bissell, M.J.; Radisky, D.C. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J. Cell Biochem., 2008, 105(1), 25-33.
48. Radisky, D.C.; Levy, D.D.; Littlepage, L.E.; Liu, H.; Nelson, C.M.; Fata, J.E.; Leake, D.; Godden, E.L.; Albertson, D.G.; Nieto, M.A.; Werb, Z.; Bissell, M.J. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 2005, 436(7047), 123-127.
49. Przybylo, J.A.; Radisky, D.C. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace. Int. J. Biochem. Cell Biol., 2007, 39(6), 1082-1088.
50. Zavadil, J.; Bottinger, E.P. TGF-beta and epithelial-tomesenchymal transitions. Oncogene, 2005, 24(37), 5764-5774.
51. Do, T.V.; Kubba, L.A.; Du, H.; Sturgis, C.D.; Woodruff, T.K. Transforming growth factor-beta1, transforming growth factorbeta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol. Cancer Res., 2008, 6(5), 695-705.
52. Yilmaz, M.; Christofori, G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev., 2009, 28(1-2), 15-33.
53. Mott, J.D.; Werb, Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol., 2004, 16(5), 558-564.
54. Sternlicht, M.D.; Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 2001, 17, 463-516.
55. Turpeenniemi-Hujanen, T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie, 2005, 87(3-4), 287-297.
56. Vihinen, P.; Kahari, V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer, 2002, 99(2), 157-166.
57. Lochter, A.; Srebrow, A.; Sympson, C.J.; Terracio, N.; Werb, Z.; Bissell, M.J. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1- dependent invasive properties. J. Biol. Chem., 1997, 272(8), 5007-5015.
58. Lochter, A.; Galosy, S.; Muschler, J.; Freedman, N.; Werb, Z.; Bissell, M.J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol., 1997, 139(7), 1861-1872.
59. Sternlicht, M.D.; Lochter, A.; Sympson, C.J.; Huey, B.; Rougier, J.P.; Gray, J.W.; Pinkel, D.; Bissell, M.J.; Werb, Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 1999, 98(2), 137-146.
60. Ota, I.; Li, X.Y.; Hu, Y.; Weiss, S.J. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. USA, 2009, 106(48), 20318-20323.
61. Illman, S.A.; Lehti, K.; Keski-Oja, J.; Lohi, J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci., 2006, 119(Pt 18), 3856-3865.
62. Rahimi, R.A.; Leof, E.B. TGF-beta signaling: a tale of two responses. J. Cell Biochem., 2007, 102(3), 593-608.
63. Massague, J.; Blain, S.W.; Lo, R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 2000, 103(2), 295-309.
64. K. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 2009, 85(8), 314-323.
65. Siegel, P.M.; Massague, J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer, 2003, 3(11), 807-821.
66. Giehl, K.; Imamichi, Y.; Menke, A. Smad4-independent TGF-beta signaling in tumor cell migration. Cells Tissues Organs, 2007, 185(1-3), 123-130.
67. Javelaud, D.; Mauviel, A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene, 2005, 24(37), 5742-5750.
68. Heldin, C.H.; Landstrom, M.; Moustakas, A. Mechanism of TGFbeta signaling to growth arrest, apoptosis, and epithelialmesenchymal transition. Curr. Opin. Cell Biol., 2009, 21(2), 166-176.
69. Pardali, K.; Moustakas, A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta, 2007, 1775(1), 21-62.
70. Wilson, C.A.; Cajulis, E.E.; Green, J.L.; Olsen, T.M.; Chung, Y.A.; Damore, M.A.; Dering, J.; Calzone, F.J.; Slamon, D.J. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells. Breast Cancer Res., 2005, 7(6), R1058-1079.
71. Kondo, M.; Cubillo, E.; Tobiume, K.; Shirakihara, T.; Fukuda, N.; Suzuki, H.; Shimizu, K.; Takehara, K.; Cano, A.; Saitoh, M.; Miyazono, K. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ, 2004, 11(10), 1092-1101.
72. Miettinen, P.J.; Ebner, R.; Lopez, A.R.; Derynck, R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol., 1994, 127(6 Pt 2), 2021-2036.
73. Shirakihara, T.; Saitoh, M.; Miyazono, K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol. Biol. Cell, 2007, 18(9), 3533-3544.
74. Morita, T.; Mayanagi, T.; Sobue, K. Dual roles of myocardinrelated transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol., 2007, 179(5), 1027-1042.
75. Zavadil, J.; Bitzer, M.; Liang, D.; Yang, Y.C.; Massimi, A.; Kneitz, S.; Piek, E.; Bottinger, E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. USA, 2001, 98(12), 6686-6691.
76. Janda, E.; Lehmann, K.; Killisch, I.; Jechlinger, M.; Herzig, M.; Downward, J.; Beug, H.; Grunert, S. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol., 2002, 156(2), 299-313.
77. Zavadil, J. New TGF-beta and Ras crosstalk in EMT. Cell Cycle, 2009, 8(2), 184.
78. Horiguchi, K.; Shirakihara, T.; Nakano, A.; Imamura, T.; Miyazono, K.; Saitoh, M. Role of Ras signaling in the induction of snail by transforming growth factor-beta. J. Biol. Chem., 2009, 284(1), 245-253.
79. Oft, M.; Peli, J.; Rudaz, C.; Schwarz, H.; Beug, H.; Reichmann, E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes. Dev., 1996, 10(19), 2462-2477.
80. Oft, M.; Heider, K.H.; Beug, H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol., 1998, 8(23), 1243-1252.
81. Uhl, M.; Aulwurm, S.; Wischhusen, J.; Weiler, M.; Ma, J.Y.; Almirez, R.; Mangadu, R.; Liu, Y.W.; Platten, M.; Herrlinger, U.; Murphy, A.; Wong, D.H.; Wick, W.; Higgins, L.S.; Weller, M. SD- 208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res., 2004, 64(21), 7954-7961.
82. Ge, R.; Rajeev, V.; Ray, P.; Lattime, E.; Rittling, S.; Medicherla, S.; Protter, A.; Murphy, A.; Chakravarty, J.; Dugar, S.; Schreiner, G.; Barnard, N.; Reiss, M. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin. Cancer Res., 2006, 12(14 Pt 1), 4315-4330.
83. Birchmeier, W.; Brinkmann, V.; Niemann, C.; Meiners, S.; DiCesare, S.; Naundorf, H.; Sachs, M. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found Symp., 1997, 212, 230-240; discussion 240-236.
84. Boyer, B.; Roche, S.; Denoyelle, M.; Thiery, J.P. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J., 1997, 16(19), 5904-5913.
85. Fujita, Y.; Krause, G.; Scheffner, M.; Zechner, D.; Leddy, H.E.; Behrens, J.; Sommer, T.; Birchmeier, W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol., 2002, 4(3), 222-231.
86. Pece, S.; Gutkind, J.S. E-cadherin and Hakai: signalling, remodeling or destruction? Nat. Cell Biol., 2002, 4(4), E72-74.
87. Bachelder, R.E.; Yoon, S.O.; Franci, C.; de Herreros, A.G.; Mercurio, A.M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelialmesenchymal transition. J. Cell Biol., 2005, 168(1), 29-33.
88. Zhou, B.P.; Deng, J.; Xia, W.; Xu, J.; Li, Y.M.; Gunduz, M.; Hung, M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol., 2004, 6(10), 931-940.
89. Stoker, M.; Gherardi, E.; Perryman, M.; Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 1987, 327(6119), 239-242.
90. Birchmeier, C.; Birchmeier, W.; Gherardi, E.; Vande Woude, G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol., 2003, 4(12), 915-925.
91. Brembeck, F.H.; Schwarz-Romond, T.; Bakkers, J.; Wilhelm, S.; Hammerschmidt, M.; Birchmeier, W. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev., 2004, 18(18), 2225-2230.
92. Brembeck, F.H.; Rosario, M.; Birchmeier, W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev., 2006, 16(1), 51-59.
93. Lee, J.M.; Dedhar, S.; Kalluri, R.; Thompson, E.W. The epithelialmesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol., 2006, 172(7), 973-981.
94. Huber, M.A.; Kraut, N.; Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol., 2005, 17(5), 548-558.
95. Fuchs, M.; Hutzler, P.; Brunner, I.; Schlegel, J.; Mages, J.; Reuning, U.; Hapke, S.; Duyster, J.; Hirohashi, S.; Genda, T.; Sakamoto, M.; Uberall, F.; Hofler, H.; Becker, K.F.; Luber, B. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors. Exp. Cell Res., 2002, 276(2), 129-141.
96. Hazan, R.B.; Norton, L. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J. Biol. Chem., 1998, 273(15), 9078-9084.
97. Marambaud, P.; Shioi, J.; Serban, G.; Georgakopoulos, A.; Sarner, S.; Nagy, V.; Baki, L.; Wen, P.; Efthimiopoulos, S.; Shao, Z.; Wisniewski, T.; Robakis, N.K. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J., 2002, 21(8), 1948-1956.
98. Heldin, C.H.; Ostman, A.; Ronnstrand, L. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta, 1998, 1378(1), F79-113.
99. Kong, D.; Wang, Z.; Sarkar, S.H.; Li, Y.; Banerjee, S.; Saliganan, A.; Kim, H.R.; Cher, M.L.; Sarkar, F.H. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells, 2008, 26(6), 1425-1435.
100. Williams, E.J.; Williams, G.; Howell, F.V.; Skaper, S.D.; Walsh, F.S.; Doherty, P. Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J. Biol. Chem., 2001, 276(47), 43879-43886.
101. Hazan, R.B.; Phillips, G.R.; Qiao, R.F.; Norton, L.; Aaronson, S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol., 2000, 148(4), 779-790.
102. Suyama, K.; Shapiro, I.; Guttman, M.; Hazan, R.B. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell, 2002, 2(4), 301-314.
103. Maretzky, T.; Reiss, K.; Ludwig, A.; Buchholz, J.; Scholz, F.; Proksch, E.; de Strooper, B.; Hartmann, D.; Saftig, P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. USA, 2005, 102(26), 9182-9187.
104. Barbera, M.J.; Puig, I.; Dominguez, D.; Julien-Grille, S.; Guaita- Esteruelas, S.; Peiro, S.; Baulida, J.; Franci, C.; Dedhar, S.; Larue, L.; Garcia de Herreros, A. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene, 2004, 23(44), 7345-7354.
105. Julien, S.; Puig, I.; Caretti, E.; Bonaventure, J.; Nelles, L.; van Roy, F.; Dargemont, C.; de Herreros, A.G.; Bellacosa, A.; Larue, L. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene, 2007, 26(53), 7445-7456.
106. Kim, H.J.; Litzenburger, B.C.; Cui, X.; Delgado, D.A.; Grabiner, B.C.; Lin, X.; Lewis, M.T.; Gottardis, M.M.; Wong, T.W.; Attar, R.M.; Carboni, J.M.; Lee, A.V. Constitutively active type I insulinlike growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol. Cell Biol., 2007, 27(8), 3165-3175.
107. Wu, Y.; Deng, J.; Rychahou, P.G.; Qiu, S.; Evers, B.M.; Zhou, B.P. Stabilization of snail by NF-kappaB is required for inflammationinduced cell migration and invasion. Cancer Cell, 2009, 15(5), 416-428.
108. Steinhusen, U.; Weiske, J.; Badock, V.; Tauber, R.; Bommert, K.; Huber, O. Cleavage and shedding of E-cadherin after induction of apoptosis. J. Biol. Chem., 2001, 276(7), 4972-4980.
109. Borghaei, R.C.; Rawlings, P.L., Jr.; Javadi, M.; Woloshin, J. NFkappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun., 2004, 316(1), 182-188.
110. Yan, C.; Wang, H.; Aggarwal, B.; Boyd, D.D. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. FASEB J., 2004, 18(3), 540-541.
111. Gilmore, T.D.; Herscovitch, M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene, 2006, 25(51), 6887-6899.
112. Cobleigh, M.A.; Vogel, C.L.; Tripathy, D.; Robert, N.J.; Scholl, S.; Fehrenbacher, L.; Wolter, J.M.; Paton, V.; Shak, S.; Lieberman, G.; Slamon, D.J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol., 1999, 17(9), 2639-2648.
113. Uemura, H.; Ishiguro, H.; Ishiguro, Y.; Hoshino, K.; Takahashi, S.; Kubota, Y. Angiotensin II induces oxidative stress in prostate cancer. Mol. Cancer Res., 2008, 6(2), 250-258.
114. Ma, L.; Teruya-Feldstein, J.; Weinberg, R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007, 449(7163), 682-688.
115. Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 2008, 9(6), 582-589.
116. Gregory, P.A.; Bert, A.G.; Paterson, E.L.; Barry, S.C.; Tsykin, A.; Farshid, G.; Vadas, M.A.; Khew-Goodall, Y.; Goodall, G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 2008, 10(5), 593-601.
117. Park, S.M.; Gaur, A.B.; Lengyel, E.; Peter, M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes. Dev., 2008, 22(7), 894-907.
118. Gibbons, D.L.; Lin, W.; Creighton, C.J.; Rizvi, Z.H.; Gregory, P.A.; Goodall, G.J.; Thilaganathan, N.; Du, L.; Zhang, Y.; Pertsemlidis, A.; Kurie, J.M. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes. Dev., 2009, 23(18), 2140-2151.
119. Iliopoulos, D.; Polytarchou, C.; Hatziapostolou, M.; Kottakis, F.; Maroulakou, I.G.; Struhl, K.; Tsichlis, P.N. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci. Signal, 2009, 2(92), ra62.
120. Wu, Y.; Zhou, B.P. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim. Biophys. Sin (Shanghai), 2008, 40(7), 643-650.
121. Davis, B.N.; Hilyard, A.C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 2008, 454(7200), 56-61.
122. Huang, T.H.; Wu, F.; Loeb, G.B.; Hsu, R.; Heidersbach, A.; Brincat, A.; Horiuchi, D.; Lebbink, R.J.; Mo, Y.Y.; Goga, A.; McManus, M.T. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem., 2009, 284(27), 18515-18524.
123. Seike, M.; Goto, A.; Okano, T.; Bowman, E.D.; Schetter, A.J.; Horikawa, I.; Mathe, E.A.; Jen, J.; Yang, P.; Sugimura, H.; Gemma, A.; Kudoh, S.; Croce, C.M.; Harris, C.C. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in neversmokers. Proc. Natl. Acad. Sci. USA, 2009, 106(29), 12085-12090.
124. Bourguignon, L.Y.; Spevak, C.C.; Wong, G.; Xia, W.; Gilad, E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J. Biol. Chem., 2009, 284(39), 26533-26546.
125. Pan, Q.; Luo, X.; Chegini, N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J. Cell Mol. Med., 2008, 12(1), 227-240.
126. Asangani, I.A.; Rasheed, S.A.; Nikolova, D.A.; Leupold, J.H.; Colburn, N.H.; Post, S.; Allgayer, H. MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008, 27(15), 2128-2136.
127. Zhu, S.; Si, M.L.; Wu, H.; Mo, Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem., 2007, 282(19), 14328-14336.
128. Keshamouni, V.G.; Jagtap, P.; Michailidis, G.; Strahler, J.R.; Kuick, R.; Reka, A.K.; Papoulias, P.; Krishnapuram, R.; Srirangam, A.; Standiford, T.J.; Andrews, P.C.; Omenn, G.S. Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify posttranscriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J. Proteome Res., 2009, 8(1), 35-47.
129. Keshamouni, V.G.; Michailidis, G.; Grasso, C.S.; Anthwal, S.; Strahler, J.R.; Walker, A.; Arenberg, D.A.; Reddy, R.C.; Akulapalli, S.; Thannickal, V.J.; Standiford, T.J.; Andrews, P.C.; Omenn, G.S. Differential protein expression profiling by iTRAQ- 2DLC-MS/MS of lung cancer cells undergoing epithelialmesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res., 2006, 5(5), 1143-1154.
130. Mathias, R.A.; Simpson, R.J. Towards understanding epithelialmesenchymal transition: a proteomics perspective. Biochim. Biophys. Acta, 2009, 1794(9), 1325-1331.
131. Zhou, C.; Nitschke, A.M.; Xiong, W.; Zhang, Q.; Tang, Y.; Bloch, M.; Elliott, S.; Zhu, Y.; Bazzone, L.; Yu, D.; Weldon, C.B.; Schiff, R.; McLachlan, J.A.; Beckman, B.S.; Wiese, T.E.; Nephew, K.P.; Shan, B.; Burow, M.E.; Wang, G. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res., 2008, 10(6), R105.